A Review of Thromboembolic Events in Hospitalized COVID-19 Patients.
Paul FonteloMrigendra M BastolaZhaonian ZhengSeo Hyon BaikPublished in: Research square (2021)
Context: A higher incidence of thromboembolic disorders in COVID-19 has been reported by many clinicians worldwide. Objective, Design and Data Sources: Selected studies found in PubMed that reported thromboembolic events were included for meta-analysis using weighted fixed and random effects. Data from 19 articles on cohort studies in patients diagnosed with COVID-19 and thromboembolic events, including thrombosis and embolism were included in this review. Results: The likelihood for developing thromboembolic disorders in hospitalized COVID-19 patients was 0.28 (95% CI 0.21â€"0.36). Conclusion: This study further validates the increased risk of VTE in COVID-19 patients when compared to healthy, non-hospitalized people, and hospitalized patients. These findings will be useful to researchers and medical practitioners caring for COVID-19 patients.
Keyphrases
- sars cov
- atrial fibrillation
- coronavirus disease
- respiratory syndrome coronavirus
- end stage renal disease
- newly diagnosed
- ejection fraction
- venous thromboembolism
- healthcare
- big data
- risk factors
- magnetic resonance
- pulmonary embolism
- peritoneal dialysis
- prognostic factors
- palliative care
- computed tomography
- artificial intelligence
- patient reported outcomes
- deep learning
- contrast enhanced